Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Stern

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Pediatrics|June 1, 1982
Ophthalmia neonatorum caused by penicillinase-producing Neisseria gonorrhoeaeH S Raucher, M J Newton, R H Stern
Journal of Clinical Pharmacology|September 2, 1998
Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadineR H Stern, J A Smithers, S C Olson
Biochemical Genetics|April 1, 1976
Strain distribution and linkage relationship of a mouse embryonic hemoglobin variantR H Stern, E S Russell, B A Taylor
European Journal of Clinical Pharmacology|April 29, 1998
Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reductionR H Stern, D M Gibson, L R Whitfield
Clinical Pharmacology and Therapeutics|July 1, 1991
Tolerance to nicotinic acid flushingR H Stern, J D Spence, D J Freeman, et al.
Journal of Clinical Pharmacology|May 11, 1999
Erythromycin coadministration increases plasma atorvastatin concentrationsP H Siedlik, S C Olson, B B Yang, et al.
Clinical Nuclear Medicine|February 1, 1995
Scintigraphic cerebral spinal fluid leak study in a child with recurrent meningitis after resection of a frontal meningoceleR H Stern, I Zanzi, S Roland, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 9, 2000
Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductaseL R Whitfield, R H Stern, A J Sedman, et al.
Journal of Clinical Pharmacology|April 29, 1998
Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatinR H Stern, B B Yang, M Horton, et al.
Journal of Clinical Pharmacology|June 27, 2000
Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitorR H Stern, B B Yang, N J Hounslow, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Pediatrics|June 1, 1982
Ophthalmia neonatorum caused by penicillinase-producing Neisseria gonorrhoeaeH S Raucher, M J Newton, R H Stern
Journal of Clinical Pharmacology|September 2, 1998
Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadineR H Stern, J A Smithers, S C Olson
Biochemical Genetics|April 1, 1976
Strain distribution and linkage relationship of a mouse embryonic hemoglobin variantR H Stern, E S Russell, B A Taylor
European Journal of Clinical Pharmacology|April 29, 1998
Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reductionR H Stern, D M Gibson, L R Whitfield
Clinical Pharmacology and Therapeutics|July 1, 1991
Tolerance to nicotinic acid flushingR H Stern, J D Spence, D J Freeman, et al.
Journal of Clinical Pharmacology|May 11, 1999
Erythromycin coadministration increases plasma atorvastatin concentrationsP H Siedlik, S C Olson, B B Yang, et al.
Clinical Nuclear Medicine|February 1, 1995
Scintigraphic cerebral spinal fluid leak study in a child with recurrent meningitis after resection of a frontal meningoceleR H Stern, I Zanzi, S Roland, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 9, 2000
Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductaseL R Whitfield, R H Stern, A J Sedman, et al.
Journal of Clinical Pharmacology|April 29, 1998
Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatinR H Stern, B B Yang, M Horton, et al.
Journal of Clinical Pharmacology|June 27, 2000
Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitorR H Stern, B B Yang, N J Hounslow, et al.
Pageof 3